{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T22:57:23Z","timestamp":1776466643359,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009886","name":"Regione Puglia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ijid.2024.02.003","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T08:25:51Z","timestamp":1707899151000},"page":"106960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Assessing the temporal and cause-effect relationship between myocarditis and mRNA COVID-19 vaccines. A retrospective observational study"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9659-0193","authenticated-orcid":false,"given":"Francesco Paolo","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donato","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Daleno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Stefanizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Migliore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Tafuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.02.003_bib0001","unstructured":"CDC. Clinical considerations: myocarditis and pericarditis after receipt of COVID-19 vaccines among adolescents and young adults. https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/myocarditis.html. [accessed 02 March, 2023]."},{"issue":"22","key":"10.1016\/j.ijid.2024.02.003_bib0002","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/heartjnl-2013-304449","article-title":"The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood","volume":"99","author":"Kyt\u00f6","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.ijid.2024.02.003_bib0003","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.amjcard.2021.03.019","article-title":"Trends in acute myocarditis related pediatric hospitalizations in the United States, 2007-2016","volume":"149","author":"Vasudeva","year":"2021","journal-title":"Am J Cardiol"},{"issue":"27","key":"10.1016\/j.ijid.2024.02.003_bib0004","doi-asserted-by":"crossref","first-page":"977","DOI":"10.15585\/mmwr.mm7027e2","article-title":"Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices\u2014United States, June 2021","volume":"70","author":"Gargano","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.ijid.2024.02.003_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41467-021-27631-8","article-title":"Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database","volume":"13","author":"Nguyen","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ijid.2024.02.003_bib0006","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ijid.2024.02.003_bib0007","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/jamacardio.2021.2833","article-title":"Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US Military","volume":"6","author":"Montgomery","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.ijid.2024.02.003_bib0008","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-052478","article-title":"Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination","volume":"148","author":"Marshall","year":"2021","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ijid.2024.02.003_bib0009","doi-asserted-by":"crossref","first-page":"e544","DOI":"10.1093\/cid\/ciac446","article-title":"Analysis of myocarditis among 252 million mRNA-1273 recipients worldwide","volume":"76","author":"Straus","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2024.02.003_bib0010","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1080\/21645515.2019.1704124","article-title":"Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospective study in Apulia Region (Italy), 2009-2017","volume":"16","author":"Stefanizzi","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"14","key":"10.1016\/j.ijid.2024.02.003_bib0011","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jacc.2022.08.003","article-title":"Myocarditis following SARS-CoV2 mRNA vaccination against COVID-19: facts and open questions","volume":"80","author":"Heymans","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ijid.2024.02.003_bib0012","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/vaccines9040358","article-title":"Influenza vaccination and health outcomes in COVID-19 patients: a retrospective cohort study","volume":"9","author":"Pedote","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.ijid.2024.02.003_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004056","article-title":"Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: a multi-database, self-controlled case series study","volume":"19","author":"Massari","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2024.02.003_bib0014","unstructured":"Italian Higher Institute of Health. COVID-19 integrated surveillance: key national data. https:\/\/www.epicentro.iss.it\/en\/coronavirus\/sars-cov-2-integrated-surveillance-data. [accessed 22 February 2023]."},{"issue":"23","key":"10.1016\/j.ijid.2024.02.003_bib0015","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against COVID-19 in Israel","volume":"385","author":"Mevorach","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2024.02.003_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.951314","article-title":"Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: a systematic review and meta-analysis","volume":"9","author":"Voleti","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ijid.2024.02.003_bib0017","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fpubh.2018.00037","article-title":"Using routine data sources to feed an immunization information system for high-risk patients\u2014a pilot study","volume":"6","author":"Martinelli","year":"2018","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijid.2024.02.003_bib0018","doi-asserted-by":"crossref","first-page":"1038043","DOI":"10.3389\/fphar.2022.1038043","article-title":"Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: a population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries","volume":"13","author":"Bots","year":"2022","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.ijid.2024.02.003_bib0019","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3390\/v14081644","article-title":"Myocardial infarction following COVID-19 vaccine administration: post hoc, Ergo Propter Hoc?","volume":"14","author":"Baronti","year":"2022","journal-title":"Viruses"},{"issue":"14","key":"10.1016\/j.ijid.2024.02.003_bib0020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.15585\/mmwr.mm7114e1","article-title":"Cardiac complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination\u2014PCORnet, United States, January 2021-January 2022","volume":"71","author":"Block","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"21","key":"10.1016\/j.ijid.2024.02.003_bib0021","doi-asserted-by":"crossref","first-page":"12906","DOI":"10.3390\/ijms232112906","article-title":"The role of inflammation in cardiovascular disease","volume":"23","author":"Henein","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"16","key":"10.1016\/j.ijid.2024.02.003_bib0022","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.3390\/ijms20163879","article-title":"Inflammation and cardiovascular diseases: the most recent findings","volume":"20","author":"Sorriento","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ijid.2024.02.003_bib0023","first-page":"e341","article-title":"Linking chronic inflammation with cardiovascular disease: from normal aging to the metabolic syndrome","volume":"3","author":"Lopez-Candales","year":"2017","journal-title":"J Nat Sci"},{"issue":"2","key":"10.1016\/j.ijid.2024.02.003_bib0024","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2259398","article-title":"Spreading of misinformation on mass media and digital platforms regarding vaccines. A systematic scoping review on stakeholders, policymakers, and sentiments\/behavior of Italian consumers","volume":"19","author":"Bianchi","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijid.2024.02.003_bib0025","unstructured":"CDC. Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/interim-considerations-us.html. [accessed 06 March 2023]."},{"key":"10.1016\/j.ijid.2024.02.003_bib0026","unstructured":"European Medicines Agency. Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis. https:\/\/www.aifa.gov.it\/documents\/20142\/1289823\/2021.07.09_com-EMA_Comirnaty_Spikevax_EN.pdf. [accessed 04 March 2023]."},{"issue":"7","key":"10.1016\/j.ijid.2024.02.003_bib0027","article-title":"COVID-19 vaccine-induced myocarditis: a systemic review and literature search","volume":"14","author":"Khan","year":"2022","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.ijid.2024.02.003_bib0028","first-page":"e32022","article-title":"COVID-19 vaccination-associated myocarditis: a literature review","volume":"14","author":"Mannan","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ijid.2024.02.003_bib0029","unstructured":"WHO. Ten threats to global health in 2019. https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019. [accessed 12 March 2023]."}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:13:16Z","timestamp":1761120796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224000286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":29,"alternative-id":["S1201971224000286"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.02.003","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the temporal and cause-effect relationship between myocarditis and mRNA COVID-19 vaccines. A retrospective observational study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"106960"}}